<--- Back to Details
First PageDocument Content
Clinical research / Food and Drug Administration / Pharmaceutical industry / Everolimus / Neuroendocrine tumor / Renal cell carcinoma / Response Evaluation Criteria in Solid Tumors / Novartis / Sirolimus / Medicine / Immunosuppressants / Macrolides
Clinical research
Food and Drug Administration
Pharmaceutical industry
Everolimus
Neuroendocrine tumor
Renal cell carcinoma
Response Evaluation Criteria in Solid Tumors
Novartis
Sirolimus
Medicine
Immunosuppressants
Macrolides

Novartis Basic registration template

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 1,56 MB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document